Prediagnostic plasma metabolomics and the risk of amyotrophic lateral sclerosis

OBJECTIVE: To identify prediagnostic plasma metabolomic biomarkers associated with amyotrophic lateral sclerosis (ALS). METHODS: We conducted a global metabolomic study using a nested case-control study design within 5 prospective cohorts and identified 275 individuals who developed ALS during follo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neurology
Autores principales: Bjornevik, Kjetil, Zhang, Zhongli, O'Reilly, Éilis J., Berry, James D., Clish, Clary B., Deik, Amy, Jeanfavre, Sarah, Kato, Ikuko, Kelly, Rachel S., Kolonel, Laurence N., Liang, Liming, Marchand, Loic Le, McCullough, Marjorie L., Paganoni, Sabrina, Pierce, Kerry A., Schwarzschild, Michael A., Shadyab, Aladdin H., Wactawski-Wende, Jean, Wang, Dong D., Wang, Ying, Manson, JoAnn E., Ascherio, Alberto
Formato: Artigo
Lenguaje:Inglês
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Null Hypothesis
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512888/
https://ncbi.nlm.nih.gov/pubmed/30926684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007401
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares